Loading...
Cronos Group Inc.
CRON.TO•TSX
Healthcare
Drug Manufacturers - Specialty & Generic
CA$2.60
CA$-0.01(-0.38%)
Cronos Group Inc. (CRON.TO) Financial Performance & Statements
Review Cronos Group Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
34.82%
↑ 34.82%
Operating Income Growth
9.75%
↑ 9.75%
Net Income Growth
155.54%
↑ 155.54%
Operating Cash Flow Growth
143.99%
↑ 143.99%
Operating Margin
-51.89%
↓ 51.89%
Gross Margin
27.65%
↑ 27.65%
Net Profit Margin
39.68%
↑ 39.68%
ROE
4.63%
↑ 4.63%
ROIC
-5.77%
↓ 5.77%
Cronos Group Inc. (CRON.TO) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Cronos Group Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $30.30M | $34.26M | $27.76M | $25.29M |
| Cost of Revenue | $19.49M | $30.65M | $21.46M | $20.80M |
| Gross Profit | $10.81M | $3.61M | $6.30M | $4.48M |
| Gross Profit Ratio | $0.36 | $0.11 | $0.23 | $0.18 |
| R&D Expenses | $1.03M | $1.24M | $962000.00 | $997000.00 |
| SG&A Expenses | $20.68M | $20.55M | $19.33M | $16.25M |
| Operating Expenses | $22.17M | $37.27M | $21.86M | $18.37M |
| Total Costs & Expenses | $41.67M | $67.92M | $43.32M | $39.18M |
| Interest Income | $11.86M | $12.46M | $13.45M | $14.24M |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $2.52M | $3.57M | $1.51M | $2.33M |
| EBITDA | -$8.84M | -$15.71M | -$13.50M | -$12.16M |
| EBITDA Ratio | -$0.29 | -$0.46 | -$0.49 | -$0.48 |
| Operating Income | -$11.37M | -$33.66M | -$15.56M | -$15.95M |
| Operating Income Ratio | -$0.38 | -$0.98 | -$0.56 | -$0.63 |
| Other Income/Expenses (Net) | $57.31M | $38.27M | $4.63M | $12.91M |
| Income Before Tax | $45.95M | $4.62M | -$10.93M | -$3.04M |
| Income Before Tax Ratio | $1.52 | $0.13 | -$0.39 | -$0.12 |
| Income Tax Expense | $2.004M | -$2.71M | -$2.17M | -$558000.00 |
| Net Income | $43.73M | $8.35M | -$8.76M | -$2.24M |
| Net Income Ratio | $1.44 | $0.24 | -$0.32 | -$0.09 |
| EPS | $0.11 | $0.02 | -$0.02 | -$0.006 |
| Diluted EPS | $0.11 | $0.02 | -$0.02 | -$0.006 |
| Weighted Avg Shares Outstanding | $382.16M | $382.16M | $382.16M | $381.44M |
| Weighted Avg Shares Outstanding (Diluted) | $382.16M | $382.16M | $382.16M | $381.44M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan